Literature DB >> 11285198

Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in DNA repair deficient XPA-/- mice.

J C Klein1, R B Beems, P E Zwart, M Hamzink, G Zomer, H van Steeg , C F van Kreijl.   

Abstract

The effects of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) were studied in DNA repair deficient XPA(-/-) mice. The nullizygous XPA-knockout mice, which lack a functional nucleotide excision repair (NER) pathway, were exposed to dietary concentrations ranging from 10 to 200 p.p.m. The results show that PhIP is extremely toxic to XPA(-/-) mice, even at doses 10-fold lower than tolerated by wild-type C57BL/6 mice. XPA(-/-) mice rapidly lost weight and died within 2 and 6 weeks upon administration of 200 and 100 p.p.m., respectively. Intestinal abnormalities like distended and overfilled ileum and caecum, together with clear signs of starvation, suggests that the small intestines were the primary target tissue for the severe toxic effects. Mutation analysis in XPA(-/-) mice carrying a lacZ reporter gene, indicated that the observed toxicity of PhIP might be caused by genotoxic effects in the small intestine. LacZ mutant frequencies appeared to be selectively and dose-dependently increased in the intestinal DNA of treated XPA(-/-) mice. Furthermore, DNA repair deficient XPC(-/-) mice, which are still able to repair DNA damage in actively transcribed genes, did not display any toxicity upon treatment with PhIP (100 p.p.m.). This suggests that transcription coupled repair of DNA damage (PhIP adducts) in active genes plays a crucial role in preventing the intestinal toxicity of PhIP. Finally, PhIP appeared to be carcinogenic for XPA(-/-) mice at subtoxic doses. Upon treatment of the mice for 6 months with 10 or 25 p.p.m. PhIP, significantly increased tumour incidences were observed after a total observation period of one year. At 10 p.p.m. only lymphomas were found, whereas at 25 p.p.m. some intestinal tumours (adenomas and adenocarcinomas) were also observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285198     DOI: 10.1093/carcin/22.4.619

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

Review 1.  Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis.

Authors:  Roderick H Dashwood
Journal:  J Biochem Mol Biol       Date:  2003-01-31

2.  TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.

Authors:  Jill E Kucab; Harry van Steeg; Mirjam Luijten; Heinz H Schmeiser; Paul A White; David H Phillips; Volker M Arlt
Journal:  Mutat Res       Date:  2015-01-30       Impact factor: 2.433

3.  DNA damage response curtails detrimental replication stress and chromosomal instability induced by the dietary carcinogen PhIP.

Authors:  Maximilian Mimmler; Simon Peter; Alexander Kraus; Svenja Stroh; Teodora Nikolova; Nina Seiwert; Solveig Hasselwander; Carina Neitzel; Jessica Haub; Bernhard H Monien; Petra Nicken; Pablo Steinberg; Jerry W Shay; Bernd Kaina; Jörg Fahrer
Journal:  Nucleic Acids Res       Date:  2016-09-05       Impact factor: 16.971

4.  Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  Masako Ochiai; Hiroshi Imai; Takashi Sugimura; Minako Nagao; Hitoshi Nakagama
Journal:  Jpn J Cancer Res       Date:  2002-05

5.  Comparative study of cytotoxic effects induced by environmental genotoxins using XPC- and CSB-deficient human lymphoblastoid TK6 cells.

Authors:  Akira Sassa; Takayuki Fukuda; Akiko Ukai; Maki Nakamura; Michihito Takabe; Takeji Takamura-Enya; Masamitsu Honma; Manabu Yasui
Journal:  Genes Environ       Date:  2019-07-16

6.  Induction of lacZ mutations in MutaMouse primary hepatocytes.

Authors:  Guosheng Chen; John Gingerich; Lynda Soper; George R Douglas; Paul A White
Journal:  Environ Mol Mutagen       Date:  2010-05       Impact factor: 3.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.